New Key Statistics Module, Z-Score and F-Score
NAS:SABS Key Ratios
Market Cap $ M | 24.00 |
Enterprise Value $ M | -6.05 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.52 |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -6.17 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 0.15 |
EV-to-EBITDA | 0.17 |
PEG | -- |
Shares Outstanding M | 9.23 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 5.24 |
Current Ratio | 5.24 |
ROA % (ttm) | -71.75 |
ROE % (ttm) | -105.43 |
ROIC % (ttm) | -162.75 |
Dividend Yield % | -- |
Altman Z-Score | -- |
SABS Number of Guru Trades
SABS Volume of Guru Trades
Gurus Latest Trades with NAS:SABS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SABS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SAB Biotherapeutics Inc Insider Transactions
No Available Data
News about NAS:SABS
Total 0- 1